Flu Season 2024: Louisiana Cases & What to Expect | Dr. Jordan Harry

Louisiana is currently experiencing a significant surge in influenza cases, leading the nation in reported infections as of December 2024. Health officials anticipate elevated case numbers will persist through the new year. The situation is particularly noteworthy as it unfolds alongside restrictions placed on the state’s health department regarding the promotion of flu, COVID-19, and mpox vaccines.

The initial wave of influenza activity in Louisiana proved particularly impactful, affecting a specific population segment disproportionately. As of today, February 3, 2026, health experts are evaluating the potential for a second wave of infections. Dr. Jordan Harry, medical director of quality and student health at Ochsner Urgent Care & Occupational Health, is sharing his expertise on the current state of the flu in Louisiana.

Understanding Respiratory Virus Trends in Louisiana

The Louisiana Department of Health (LDH) is actively monitoring respiratory virus activity through its Respiratory Emergency Department Visits Data dashboard. This system utilizes data from Louisiana emergency departments participating in the National Syndromic Surveillance Program (NSSP) to track trends in COVID-like illness (CLI), influenza-like illness (ILI), and respiratory syncytial virus (RSV)-like illness.

The LDH defines these illnesses based on specific criteria. CLI is identified by an emergency department visit with a chief complaint of fever and either cough or shortness of breath, or a COVID-19 discharge diagnosis – excluding visits with an influenza discharge diagnosis. ILI is defined as a visit with fever or chills, and either cough, sore throat, or upper respiratory infection, or an influenza discharge diagnosis. RSV-like illness is identified by a visit with a chief complaint including RSV, bronchiolitis, or syncytial virus, or an RSV discharge diagnosis.

Data are presented as a percentage, representing the proportion of emergency department visits attributable to each illness type relative to all ED visits within a specific region or age group. This allows for a granular understanding of how these viruses are impacting different populations across the state.

National Influenza Surveillance

The Centers for Disease Control and Prevention (CDC) provides weekly U.S. Influenza Surveillance Reports, known as FluView. These reports offer a comprehensive overview of influenza activity nationwide, though data are preliminary. The CDC also offers an interactive FluView platform for users to explore influenza surveillance data in a customized format.

The Impact of Restrictions on Public Health Messaging

The current flu surge in Louisiana is occurring against a backdrop of limitations placed on the state’s health department. Reports indicate that the department has been barred from actively promoting flu shots, as well as vaccines for COVID-19 and mpox. This restriction raises concerns about the potential impact on vaccination rates and public health efforts to mitigate the spread of these viruses.

While the specific reasons for these restrictions have not been detailed in the provided sources, the timing coincides with a period of increased influenza activity and underscores the importance of clear and accessible public health messaging during respiratory virus season.

What the Data Shows

The data collected through the NSSP and analyzed by the LDH provides valuable insights into the current respiratory virus landscape in Louisiana. By tracking emergency department visits and identifying trends in CLI, ILI, and RSV-like illness, health officials can gain a better understanding of the burden these viruses are placing on the healthcare system and the populations most affected.

The weekly updates to the LDH dashboard, occurring every Friday with data up to the previous Saturday, are crucial for monitoring the evolving situation and informing public health interventions. The CDC’s FluView reports complement this local data by providing a national perspective on influenza activity.

Looking Ahead

As Louisiana continues to navigate this surge in influenza cases, ongoing surveillance and data analysis will be essential. The potential for a second wave of infections remains a concern, and the restrictions on the health department’s ability to promote vaccination efforts add a layer of complexity to the public health response. The expertise of medical professionals like Dr. Harry will be vital in guiding individuals and communities through this challenging period.

We see important to remember that respiratory viruses like influenza, COVID-19, and RSV can cause significant illness, particularly in vulnerable populations. Staying informed about the latest data and following public health recommendations are crucial steps in protecting oneself and others.